Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
about
Engineering liposomal nanoparticles for targeted gene therapy.Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.A Modular Coassembly Approach to All-In-One Multifunctional Nanoplatform for Synergistic Codelivery of Doxorubicin and Curcumin.
P2860
Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Galactosylated Liposomes for T ...... NA to Hepatocellular Carcinoma
@en
Galactosylated Liposomes for T ...... A to Hepatocellular Carcinoma.
@nl
type
label
Galactosylated Liposomes for T ...... NA to Hepatocellular Carcinoma
@en
Galactosylated Liposomes for T ...... A to Hepatocellular Carcinoma.
@nl
prefLabel
Galactosylated Liposomes for T ...... NA to Hepatocellular Carcinoma
@en
Galactosylated Liposomes for T ...... A to Hepatocellular Carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Galactosylated Liposomes for T ...... NA to Hepatocellular Carcinoma
@en
P2093
Dong-Eun Kim
Hyun-Young Jo
Je-Yoel Cho
Keun-Sik Kim
Pyung-Hwan Kim
P2860
P356
10.3390/NANO6080141
P50
P577
2016-07-30T00:00:00Z